RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
more
Strides Pharma International AG
Bosch Healthcare Solutions GmbH
Bosch Healthcare Solutions GmbH
LTS Lohmann Therapie-Systeme AG
Leipzig Tourismus und Marketing GmbH